Trial intelligence / Profile preview

Bioequivalence of Topiramate 100 mg film-coated tablets vs Topamax in healthy Thai volunteers (fasting)

TCTR20230511003Phase 1Unknown

Sponsor
Bio-innova
Start
Aug 2023
Modality
Small Molecules
Countries
1
01

Overview

Phase 1, randomised, open-label trial of topiramate (2 arms), sponsored by Bio-innova. Primary endpoint: Bioequivalence of topiramate test vs reference. Status: unknown.

02

Drugs

topiramate

Beyond the preview

Go deeper on TCTR20230511003.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20230511003.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call